Examining elderly gastric cancer patients (>75 years) in the U.S., this study, using propensity score matching, reveals that neoadjuvant chemotherapy (NAC) utilization increased from 2013 to 2019 (21% to 42.7%). After matching, 1958 patients showed that those receiving NAC experienced enhanced oncological outcomes following resection for locally advanced gastric cancer. The findings advocate for the potential benefits of NAC in improving overall survival and other outcomes in this elderly patient population.
Journal Article by Rawicz-Pruszyński K, Endo Y (…) Pawlik TM et 7 al. in Ann Surg Oncol
© 2023. Society of Surgical Oncology.